Hughes & Company | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

23,341 results for “Hughes & Company”

Trials

View all 3046 →

Opinions of Company Representatives About Neuromodulation

39 participants · First posted Aug 19, 2021

Loves Company: Combatting Emotional Disturbance in the Digital Age

212 participants · First posted Feb 23, 2018

Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease

214 participants · First posted May 21, 2007

Drugs

View all 75 →

Orphanin antagonists (The GI company)

UC1MT (Biohaven Pharmaceutical Holding Company/University of Connecticut)

APP targeted antibody(Genome & Company)

Organizations

View all 1648 →

JENNIFER HUGHES

Australia

Pamela Hughes

United States

Parker Hughes Cancer Center

United States

News

View all 18572 →

PatientIQ Raises $30M Series C to Scale EHR-Integrated Outcomes Intelligence Platform

Faron Pharmaceuticals Appoints Ralph Hughes as Chief Business Officer to Advance Immunotherapy Pipeline

Summit Therapeutics Completes Enrollment in Phase III HARMONi Trial and Receives FDA Fast Track Designation for Ivonescimab

Page 1 of 2335